13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

Page 14 of 14

Page 14 of 14 – SEC Filing

Exhibit B

Due to the relationships between them, the
reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3)
of the Securities Exchange Act of 1934.

Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)

Page 14 of 14